Integer Holdings Corporation
ITGR Healthcare Medical Devices
Integer Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 7.98% from fiscal 2024.
- Revenue
- −3.86%
- EPS
- −61.0%
- Free cash flow
- −65.2%
- Total debt
- +4.06%
Quarter to September 2026, against a year earlier
Follow ITGR
Alert me
Integer Holdings Corporation (ITGR) P/B ratio
As of 6 November 2026, Integer Holdings Corporation (ITGR) trades at a P/B ratio of 2.5×. Over the past ten years it has ranged from 0.8× (October 2016) to 3.0× (January 2025); the current reading is higher than 85% of that period. That is in line with the Medical Devices industry median of 2.5× and above the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 1.6× | (43.28%) |
| FY2024 | 2.8× | 27.62% |
| FY2023 | 2.2× | 34.66% |
| FY2022 | 1.6× | (23.23%) |
| FY2021 | 2.1× | (0.64%) |
| FY2020 | 2.1× | (7.86%) |
| FY2019 | 2.3× | (1.47%) |
| FY2018 | 2.3× | 44.81% |
| FY2017 | 1.6× | 27.25% |
| FY2016 | 1.3× | (15.45%) |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Sep 2026 | 2.5× | 34.67% |
| Jun 2026 | 1.8× | 4.03% |
| Mar 2026 | 1.8× | 13.97% |
| Dec 2025 | 1.6× | (24.88%) |
| 43 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| NEOG Neogen Corporation compare | 1.2× |
| ITGR Integer Holdings Corporation | 2.5× |
| LIVN LivaNova PLC compare | 3.8× |
| TMDX TransMedics Group, Inc. compare | 4.3× |
| UFPT UFP Technologies, Inc. compare | 5.0× |
| AXGN AxoGen, Inc. compare | 5.4× |
| HAE Haemonetics Corporation compare | 6.2× |
| TXG 10x Genomics compare | 9.2× |
| IRTC iRhythm Holdings, Inc. compare | 24.4× |
| Medical Devices industry median | 2.5× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on ITGR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement